We sought to determine the prevalence of human respiratory syncytial virus (HRSV) in people in Iran between the year 1996 and 2016. Methods: Prevalence of HRSV in Iran was determined from 1996 to 2016 using data from PubMed, Web of Science, EMBASE, Cochrane Library, Google Scholar and Iranian databases. Analysis was performed by Comprehensive Meta-Analysis software. Result: Theprevalenceof HRSV infections was 18.0% (95% CI: 14.6-22.0) in people in different regions of Iran. Additionally, the incidence of HRSV in north, center, west and south of Iran were 16.4% (95% CI: 11.8-22.4), 20.0% (95% CI: 15.5-25.5), 16.8% (95% CI: 10.0-27.0) and 10.6% (95% CI: 2.4-36.9), respectively. Conclusion: According to the high prevalence of HRSV infection among people with respiratory infections in Iran, HRSV screening and evaluating of co-circulate HRSV genotypes can be helpful for vaccination design in the future.
Medical Subject Headings, titles and abstracts with the help of Boolean operators (and, or): respiratory syncytial virus, HRSV, Prevalence, Incidence and Iran. We also searched bibliographies of retrieved articles for additional articles.
Inclusion & exclusion criteria
All original research articles presenting cross-sectional studies on the prevalence of HRSV in Iran were considered. The selection of articles for review was completed based on three factors: titles, abstracts and full texts. In safety evaluation, we further included studies only if they were conducted with more than 100 subjects. Articles excluded from the analysis were discounted for the following reasons: they considered only subpopulations such as H1N1 cases or they studied other types of respiratory pathogens; they were review articles; reported in languages other than English or Persian; meta-analyses or systematic reviews; and duplicate publication of the same study. Articles available only in abstract form were also excluded.
Data extraction & definitions
From the included studies, the following variables were extracted: author's name, study time, publication year, settings, patient sample size, number of HRSV isolates, source of isolates and prevalence of HRSV. Two investigators extracted data from all of the included studies independently. Inconsistencies between the reviewers were discussed to obtain consensus.
Quality assessment
Included studies were appraised for quality, using a quality assessment checklist, which was designed by the Joanna Briggs Institute [19] .
Meta-analysis
Analysis was performed using Comprehensive Meta-Analysis (V2.2, Bio stat) software. Generally, fixed or random effect models were used but this was dependent on statistical heterogeneity between studies to calculate summary estimates. Statistical heterogeneity was quantified by the I 2 statistic. In order to remove possible publication bias, Egger weighted regression methods were deployed. The value of p < 0.05 was considered indicative of statistically significant publication bias.
Results

Characteristics of included studies
Initially, a total of 265 articles were collected. In secondary screening, 211 of them were excluded on the basis of the title and abstract evaluation (Figure 1 ). In the next step, 27 of the remaining 54 studies were excluded upon a full text search. A total of 27 eligible studies were chosen for final analysis. Characteristics of the included articles are summarized in Table 1 . Geographic location of studies covered east, west, north, south and center of Iran, and majority (n [%]) of the studies were from center of Iran. Unfortunately, no studies reporting data from the east of Iran met the criteria to be included in our meta-analysis. Diagnostic methods for HRSV mainly included molecular and nonmolecular methods. Additionally, HRSV species were isolated from nasopharyngeal swabs, nasopharyngeal aspirate, throat swabs, respiratory specimens and serum samples.
The prevalence of human respiratory syncytial virus strains
The pooled prevalence of HRSV infections among molecular testing-positive cases of HRSV was 18.0 (95% CI: 14.6-22.0) ( Table 2 ). The heterogeneity test indicated that there were heterogeneities between studies (I 2 = 91.0; p < 0.001). As it is shown in Table 2 , Figure 2 shows the forest plot of meta-analysis of HRSV prevalence. Based on data in Table 2 & Figure 3 , no evidence of publication bias was observed (p > 0.05 for Egger weighted regression analysis). As presented in Table 2 , the outbreak of the HRSV in post-2009 studies is more than the previous reports. Table 3 shows the stratified analyses according to the geographic areas of included studies. The prevalence of the virus in the center, west, north and south of Iran was reported as 20, 16.8, 16.4 and 10.6%, respectively. Unfortunately, none of the studies in the east of Iran met the criteria to be included in our meta-analysis. Also in this study, the prevalence of HRSV in Iran was evaluated based on the detection method of HRSV (Tables 4  & 5 ). As shown in Table 4 , detection of HRSV by molecular and nonmolecular methods was reported 19.4 and 16.2%, respectively. Figure 4 shows the used method for HRSV detection, and distribution of HRSV infections in different parts of Iran has been shown in Figure 5 . Also, most of HRSV genotypes among patients with HRSV infection were GA1 and GA2, respectively ( Figure 6 ).
Discussion
The current systematic review and meta-analysis reports the prevalence of HRSV infections in Iran. Our analyses showed that the prevalence of HRSV infections was 18.0% (95% CI: 14.6-22.0) among patients with respiratory infections in different parts of Iran (Table 2 ). According to the results of our study, the HRSV incidence rate was higher in the center of Iran . This could be explained by the use of more sensitive molecular detection tools, HRSV identification methods and increased knowledge about HRSV detection [20] . The epidemiology of HRSV has gradually changed since its emergence was reported [21, 22] . Initially there were occasional reports, but now it has become one of the established causes of community acquired pneumonia [23] .The high prevalence of HRSV (18.0%) among viral respiratory infection may be due to several factors [24, 25] . First and above all is the lack of efficient vaccine control and prevention of HRSV infection [26] . Clinical aspects of HRSV infections highlight four different goal societies or aim populations for vaccines: the HRSV infant, the HRSV child ≥6 months of age, pregnant women and the elderly. Due to different immunity features in each group, goal societies may need various vaccination strategies to prevent HRSV infection. Another factor is the high variation of nucleic acid sequence of the G glycoprotein. As previously mentioned, it is the G glycoprotein that mediates HRSV adsorption through the host-cell surface; in conclusion, polymorphism in the G glycoprotein gene is the key hurdle in the development of an HRSV vaccine. Third, as infants age, maternity immunity decreases and due to their naive immune system, this leaves infants vulnerable to HRSV infections. Hospital acquired infection in high population societies such as Iran can be regarded as the fourth factor. Moreover, the presence of diverse infectious strains associated with HRSV has added to the problem [27] .
Many studies have indicated that A and B isolates co-circulate during epidemics, with group A generally overcoming group B [28] . This is probably due to several factors. It has been considered that infection with serogroup B results in a lower intensity disease, therefore probably identified less often. The next hypothesis is that infection with serogroup B can generate long-lasting serogroup-particular immunity. Furthermore, serogroup B glycoprotein G could elicit a better antibody response than serogroup A glycoprotein G. It seems determination of HRSV genotypes is very important to the design of infection control, due to the lack of prevalence data, we do not know exactly which serogroups each HRSV isolate belonged to. It was only in the few studies that were performed in recent years that this information was available. These studies show that group A genotypes were isolated RT-PCR 45%
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Percentage of used HRSV detection methods in studies group A viruses belonged to three genotypes: GA1, GA2 and GA5, and the group B viruses were in the BA genotype ( Figure 6 ) [29] [30] [31] . Additional to epidemiological properties, remarkable molecular mutations in circulating isolates can account for different virulence and pathogenicity to HRSV infection. The nucleotide changes in the glycoprotein G gene results in amino acid changes that could affect the pattern of N-and O-glycosylation sites. Two N-glycosylation sites at amino acid positions 251 and 294, and three motifs at position 238 were detected among group A viruses circulating in Iran. However in group B viruses, only one N-glycosylation site at amino acid position 310 and one O-glycosylation site at position 234 were identified [29] . Different patterns of N-and O-glycosylation sites between HRSV-A and -B are important differences for virus antigenicity and can result in an increased pathogenesis 
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Bandar-e Langeh and an enhanced duplication rate in the lower region of respiratory tract [32, 33] . As shown in the results of this meta-analysis, the prevalence of HRSV determined in studies using molecular methods are more accurate than studies using nonmolecular methods such as enzyme-linked immunosorbent assay, indirect immunofluorescence, immunochromatography and direct immunofluorescence. It can be said that molecular methods are the gold standard for HRSV detection. Although to confirm this claim would require further studies. There were some limitations to this study which should be discussed. First of all, only published studies were accepted in the present review and meta-analysis. Thus, as with any systematic review, the existence of potential publication bias should be considered. Second, heterogeneity was detected among the included studies. Third, it cannot fully represent the prevalence of HRSV in Iran because the extent of HRSV has not yet been examined in many regions of Iran. Also, some articles lacked detailed information such as age of the patients studied and the various sections in which the patients were admitted. Fourth, being a prevalence survey, we are unable to determine risk factors for HRSV colonization or infection.
Conclusion & future perspective
The increase in the number of HRSV infections is a major public health problem in Iran and merits further attention by health authorities, physicians and microbiologists. The regular surveillance of respiratory-associated infection would provide more information regarding pathogenic HRSV types and most importantly aid toward the design of an effective vaccine. A clearer picture of HRSV prevalence would be very useful and may facilitate more accurate action for prevention and control of HRSV infections in Iran. In particular, the introduction of HRSV screening based on rapid and reliable diagnosis during inpatient admission would be indispensable.
Summary points
r Evaluation of human respiratory syncytial virus (HRSV) infection in Iranian people.
r Distribution of HRSV infections in different points of Iran.
r Evaluation of HRSV infections based on molecular and nonmolecular methods.
r Distribution of HRSV genotypes among patients with HRSV infection.
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